These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12910612

  • 1. [Evaluation of selected parameters of blood coagulation and fibrinolysis system in patients undergoing total hip replacement surgery with normovolemic hemodilution procedure and standard enoxaparine prophylaxis].
    Piecuch W, Sokołowska B, Dmoszyńska A, Furmanik F.
    Chir Narzadow Ruchu Ortop Pol; 2003; 68(2):95-9. PubMed ID: 12910612
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B, Piecuch W, Walter-Croneck A, Dmoszyńska A, Furmanik F.
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [Abstract] [Full Text] [Related]

  • 3. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
    Biagini D, Filippucci E, Agnelli G, Pagliaricci S.
    Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
    [Abstract] [Full Text] [Related]

  • 4. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J, Lützner J, Donath L, Tittl L, Knoth H, Radke OC, Kuhlisch E, Stange T, Hartmann A, Günther KP, Weiss N, Werth S.
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [Abstract] [Full Text] [Related]

  • 6. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ, RE-NOVATE II Study Group.
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [Abstract] [Full Text] [Related]

  • 7. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P, Christoforidou A, Kouklakis G, Tsalikidis C, Dimakis C, Laftsidis P, Virgiliou A, Simopoulos C, Pitiakoudis M.
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [Abstract] [Full Text] [Related]

  • 8. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T, Malý R, Urban K, Sponer P.
    Acta Chir Orthop Traumatol Cech; 2011 Feb; 78(2):101-5. PubMed ID: 21575551
    [Abstract] [Full Text] [Related]

  • 9. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
    Green L, Lawrie AS, Patel R, Stephens RC, Mackie IJ, Chitolie A, Haddad FS, Machin SJ.
    Thromb Res; 2012 Nov; 130(5):775-9. PubMed ID: 22245224
    [Abstract] [Full Text] [Related]

  • 10. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.
    Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM.
    J Bone Joint Surg Br; 2007 Jun; 89(6):799-807. PubMed ID: 17613508
    [Abstract] [Full Text] [Related]

  • 11. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P, De Groote K, Annemans L.
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [Abstract] [Full Text] [Related]

  • 12. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo.
    Jones CI, Payne DA, Hayes PD, Naylor AR, Bell PR, Thompson MM, Goodall AH.
    J Vasc Surg; 2008 Sep; 48(3):715-22. PubMed ID: 18572351
    [Abstract] [Full Text] [Related]

  • 13. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F.
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [Abstract] [Full Text] [Related]

  • 14. [Effects of thromboprophylaxis duration on coagulation indicators after total hip replacement].
    Zhang H, Lin J, Li H, Guan Z, Zhou D, Kou B, Wei W.
    Zhonghua Yi Xue Za Zhi; 2014 Feb 25; 94(7):525-8. PubMed ID: 24767296
    [Abstract] [Full Text] [Related]

  • 15. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
    Turpie AG, Gallus AS, Hoek JA, Pentasaccharide Investigators.
    N Engl J Med; 2001 Mar 01; 344(9):619-25. PubMed ID: 11228275
    [Abstract] [Full Text] [Related]

  • 16. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr 01; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 17. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.
    Vallely MP, Bannon PG, Bayfield MS, Hughes CF, Kritharides L.
    Heart Lung Circ; 2009 Apr 01; 18(2):123-30. PubMed ID: 19081297
    [Abstract] [Full Text] [Related]

  • 18. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C, Mouret P.
    Semin Vasc Med; 2005 Aug 01; 5(3):266-75. PubMed ID: 16123914
    [Abstract] [Full Text] [Related]

  • 19. Blood coagulation during and after normovolemic hemodilution in elective surgery.
    Rosberg B.
    Ann Clin Res; 1981 Aug 01; 13 Suppl 33():84-8. PubMed ID: 6177276
    [Abstract] [Full Text] [Related]

  • 20. Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters.
    Suga N, Miura N, Kitagawa W, Morita H, Banno S, Imai H.
    Amyloid; 2012 Jun 01; 19(2):61-5. PubMed ID: 22417630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.